Irinotecan Hydrochloride Injection

DRUG2 trials

Sponsors

Taizhou Hanzhong biomedical co. LTD, RemeGen Co., Ltd.

Conditions

Gastric CancerHER2 Overexpressing Gastric CarcinomaStomach Cancer

Phase 3

HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer

Taizhou Hanzhong biomedical co. LTDStomach Cancer

Start: 2020-09-16End: 2023-08-10Target: 560Updated: 2021-01-28

A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression

RemeGen Co., Ltd.Gastric Cancer, HER2 Overexpressing Gastric Carcinoma

Start: 2021-03-24End: 2025-06-30Target: 351Updated: 2023-12-21